Urate-lowering therapy tablets targeting gouty arthritis. Sourced from pharmaceutical producers and supplied by B2B distributors to endocrinology and rheumatology units. Acquired by healthcare facilities and outpatient services for chronic hyperuricemia management in arthritic patient populations.